Unsuspected skin metastasis of adenocarcinoma of the prostate in a patient on goserelin (Zoladex)
Prostate cancer remains the most common noncutaneous cancer in men, especially in this era of prostate-specific antigen assay. Prostate cancer metastases have been known to commonly affect the lymphatics, bones, and lungs. Prostate cancer metastasis to the skin is very rare (<1%) and often signif...
Main Authors: | Timothy Uzoma Mbaeri, Jideofor Chukwuma Orakwe, Ogochukwu I Ezejiofor |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2018-01-01
|
Series: | Nigerian Journal of Surgery |
Subjects: | |
Online Access: | http://www.nigerianjsurg.com/article.asp?issn=1117-6806;year=2018;volume=24;issue=2;spage=138;epage=141;aulast=Mbaeri |
Similar Items
-
Identification of predictors based on drug targets highlights accurate treatment of goserelin in breast and prostate cancer
by: Yue Zhao, et al.
Published: (2021-01-01) -
Cost-utility analysis of adjuvant goserelin (Zoladex) and adjuvant chemotherapy in premenopausal women with breast cancer
by: Cheng Tsui, et al.
Published: (2012-01-01) -
Restart of androgen deprivation therapy after goserelin induced pituitary apoplexy in a patient with disseminated prostate cancer a case report and five-years follow-up
by: Belal Aljabri, et al.
Published: (2021-07-01) -
Efficacy and safety of goserelin combined with adjuvant chemotherapy in premenopausal women with breast cancer
by: Yang Wang, et al.
Published: (2015-11-01) -
Efficacy of switching therapy of luteinizing hormone–releasing hormone analogue for advanced prostate cancer
by: Yuan-Chi Shen, et al.
Published: (2016-11-01)